The University of Chicago Header Logo

Connection

Bulent Aydogan to Humans

Back to Details
This is a "connection" page, showing publications Bulent Aydogan has written about Humans.
Bulent Aydogan
Connection Strength
0.344
Humans
  1. Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Invest. 2022 Apr; 45(4):865-874.
    View in: PubMed
    Score: 0.028
  2. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac. Med Phys. 2020 Nov; 47(11):5455-5466.
    View in: PubMed
    Score: 0.025
  3. A practical method for quantifying dose in bone and lung using TLDs when using 6 and 15 MV photon beams. Phys Med Biol. 2020 03 06; 65(5):05NT01.
    View in: PubMed
    Score: 0.024
  4. ENERGY RESPONSE FACTOR of BeO DOSEMETER CHIPS: A MONTE CARLO SIMULATION AND GENERAL CAVITY THEORY STUDY. Radiat Prot Dosimetry. 2019 Dec 31; 185(3):303-309.
    View in: PubMed
    Score: 0.024
  5. Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique. J Appl Clin Med Phys. 2019 Aug; 20(8):21-28.
    View in: PubMed
    Score: 0.023
  6. A preplanning method for stereotactic radiosurgery to improve treatment workflow. J Appl Clin Med Phys. 2016 05 08; 17(3):171-179.
    View in: PubMed
    Score: 0.019
  7. Increased dose near the skin due to electromagnetic surface beacon transponder. J Appl Clin Med Phys. 2015 May 08; 16(3):4930.
    View in: PubMed
    Score: 0.017
  8. Verification of dose distribution for volumetric modulated arc therapy total marrow irradiation in a humanlike phantom. Med Phys. 2012 Jan; 39(1):281-8.
    View in: PubMed
    Score: 0.014
  9. Total marrow irradiation with RapidArc volumetric arc therapy. Int J Radiat Oncol Biol Phys. 2011 Oct 01; 81(2):592-9.
    View in: PubMed
    Score: 0.013
  10. Linear accelerator-based intensity-modulated total marrow irradiation technique for treatment of hematologic malignancies: a dosimetric feasibility study. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1256-65.
    View in: PubMed
    Score: 0.013
  11. AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol. 2010 Oct; 12(5):463-7.
    View in: PubMed
    Score: 0.013
  12. A novel functional CT contrast agent for molecular imaging of cancer. Phys Med Biol. 2010 Aug 07; 55(15):4389-97.
    View in: PubMed
    Score: 0.012
  13. Feasibility study for linac-based intensity modulated total marrow irradiation. Med Phys. 2008 Dec; 35(12):5609-18.
    View in: PubMed
    Score: 0.011
  14. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1504-10.
    View in: PubMed
    Score: 0.011
  15. Linac-based intensity modulated total marrow irradiation (IM-TMI). Technol Cancer Res Treat. 2006 Oct; 5(5):513-19.
    View in: PubMed
    Score: 0.010
  16. A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2006 May 01; 65(1):266-73.
    View in: PubMed
    Score: 0.009
  17. A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
    View in: PubMed
    Score: 0.007
  18. Sensitive detection and quantification of SARS-CoV-2 in saliva. Sci Rep. 2021 06 14; 11(1):12425.
    View in: PubMed
    Score: 0.007
  19. The clinical utility of imaging methods used to measure hypoxia in cervical cancer. Br J Radiol. 2020 Jul; 93(1111):20190640.
    View in: PubMed
    Score: 0.006
  20. Utilizing the TrueBeam Advanced Imaging Package to monitor intrafraction motion with periodic kV imaging and automatic marker detection during VMAT prostate treatments. J Appl Clin Med Phys. 2020 Mar; 21(3):184-191.
    View in: PubMed
    Score: 0.006
  21. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
    View in: PubMed
    Score: 0.005
  22. A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals. Med Phys. 2015 Aug; 42(8):4629-35.
    View in: PubMed
    Score: 0.004
  23. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy. J Med Imaging Radiat Oncol. 2015 Jun; 59(3):386-93; quiz 394.
    View in: PubMed
    Score: 0.004
  24. Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. Biol Blood Marrow Transplant. 2014 Dec; 20(12):2034-41.
    View in: PubMed
    Score: 0.004
  25. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. Clin Lung Cancer. 2014 Sep; 15(5):365-71.
    View in: PubMed
    Score: 0.004
  26. Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways. Tumour Biol. 2014 Mar; 35(3):2403-15.
    View in: PubMed
    Score: 0.004
  27. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol. 2013 Feb; 34(1):203-14.
    View in: PubMed
    Score: 0.004
  28. Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression. J Lipid Res. 2012 Aug; 53(8):1553-68.
    View in: PubMed
    Score: 0.004
  29. Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines. Tumour Biol. 2011 Feb; 32(1):87-98.
    View in: PubMed
    Score: 0.003
  30. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):800-7.
    View in: PubMed
    Score: 0.003
  31. Validation of temporal optimization effects for a single fraction of radiation in vitro. Int J Radiat Oncol Biol Phys. 2009 Nov 15; 75(4):1240-6.
    View in: PubMed
    Score: 0.003
  32. A multi-institutional acute gastrointestinal toxicity analysis of anal cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemotherapy. Radiother Oncol. 2009 Nov; 93(2):298-301.
    View in: PubMed
    Score: 0.003
  33. Small-scale dosimetry: challenges and future directions. Semin Nucl Med. 2008 Sep; 38(5):367-83.
    View in: PubMed
    Score: 0.003
  34. Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Apr 01; 70(5):1431-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.